FDA approves virtual reality rehab device for stroke, brain injury patients

The Food and Drug Administration on Wednesday approved MindMaze’s upper-limb rehabilitation platform, MindMotion Pro.

Advertisement

The neuro-technology platform uses 3-D motion tracking cameras, creating a virtual reality environment to aid stroke patients and individuals with other traumatic injuries.

The platform maps patients’ movements onto 3-D avatars and leads them through various rehabilitation exercises based on “standardized neurorehabilitation principles,” according to a news release.

Patients can use the platform as soon as four days post-stroke.

More articles on supply chain:

Viewpoint: Why healthcare needs more ‘me too’ drugs
Viewpoint: Pharma should give trial participants a say in pricing new drugs
Magellan vein-based blood tests underreported lead levels, says health officials

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.